This topic contains a solution. Click here to go to the answer

Author Question: Unlike long-chain fatty acids, short-chain fatty acids from the diet leave the enterocyte via the ... (Read 58 times)

yoooooman

  • Hero Member
  • *****
  • Posts: 557
Unlike long-chain fatty acids, short-chain fatty acids from the diet leave the enterocyte via the portal vein and go directly to the liver.
  Indicate whether the statement is true or false

Question 2

Adipocytes' primary function is to store fat as triacylglycerol; thus, they do not require glycolysis and the TCA cycle for energy needs.
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

briseldagonzales

  • Sr. Member
  • ****
  • Posts: 303
Answer to Question 1

TRUE

Answer to Question 2

FALSE




yoooooman

  • Member
  • Posts: 557
Reply 2 on: Aug 21, 2018
Excellent


sarah_brady415

  • Member
  • Posts: 328
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Everyone has one nostril that is larger than the other.

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library